Chimerized anti-ICOS 314.8 monoclonal antibodies inhibit tumor cells and regulatory T cells in patients with Sézary syndrome. (September 2022) - Amatore, FA; Barre, M; Orlanducci, F; Lopez, M; Castellano, R; Ram-Wolff, C; Gorvel, L; Goubard, A; Gaudy-Marqueste, C; Bagot, M; Bensussan, A; Delaporte, E; et al.